Weight-loss drugs could reduce COVID-related deaths: Study
A new study found that weekly injections of 2.4 mg of semaglutide could lower the risk of deaths related to COVID-19, marking another potential benefit of these blockbuster drugs.
Eli Lilly cuts cost of certain Zepbound doses by at least 50%
Eli Lilly is launching more supply of its weight loss drug Zepbound. The new single-dose vials will be priced lower than "all other incretin GLP-1 medicines for obesity."
Eli Lilly's Zepbound reduces type 2 diabetes risk, study shows
Eli Lilly announced results of a study in which weekly shots of tirzepatide injections significantly reduced the risk of progression to type 2 diabetes by 94% among certain adults.
Novo Nordisk slashes outlook even as it ramps up Wegovy production
Danish drug maker Novo Nordisk lowered its full year forecast even as tens of thousands of patients start the highly coveted weight loss drug, Wegovy, every week.
Nearly 7,000 pounds of hot dogs recalled due to lack of inspection
Thousands of pounds of hot dogs are being recalled after officials discovered that they were produced and shipped to restaurants and hotels without being federally inspected.
Study reveals smoking contributes to 30% of cancer deaths
Fox News senior correspondent Jonathan Serrie reports on a promising new study from the American Cancer Society researching various prevention methods.
Dr. Marc Siegel issues a warning to summertime swimmers amid a surge of pool illnesses
Fox News medical contributor Dr. Marc Siegel weighs in on Eli Lilly’s Alzheimer’s drug and breaks down the most common pool-related illnesses.
Charles Payne: Biden should not beat up Big Pharma for making money
'Making Money' host Charles Payne reacts to Biden calling on Novo Nordisk and Eli Lilly to cut weight loss drug prices.
Supreme Court blocks bankruptcy deal for OxyContin maker Purdue Pharma
The U.S. Supreme Court on Thursday struck down Purdue Pharma's nationwide settlement agreement, delaying compensation for opioid victims.
Ozempic craze: Novo Nordisk invests $4.1B in US to expand manufacturing
Novo Nordisk is ramping up the manufacturing capacity of its obesity-related drugs as demand for Wegovy and Ozempic continues to surge. It's pouring $4.1 billion to expand its facility.
Ro GLP-1 tracker helps people crowdsource supply and report shortages: Zach Reitano
RO CEO Zach Reitano explains how his company tracks Ozempic and Wegovy supply on 'The Claman Countdown.'
Dr. Fauci was a 'miserable failure,' betrayed the trust of American people: Rep. Ronny Jackson
Rep. Ronny Jackson, R-Texas, reacts to Anthony Fauci denying responsibility for various COVID mandates on 'The Big Money Show.'
Weight-loss drugs are a risky but real solution to a lot of health problems: Johann Hari
'Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs' author Johann Hari discusses the side effects of drugs like Ozempic and Wegovy on 'The Big Money Show.'
Anger is toxic, it's poison to your health: Dr. Janette Nesheiwat
Fox News contributor Dr. Janette Nesheiwat discusses a new study that says anger can increase heart attack risk on 'Cavuto: Coast to Coast.'
Florida tracks migrant health care costs
Fox News reporter Danamarie McNicholl has the latest on Florida's $566 million medical bill on 'The Evening Edit.'
Prenosis CEO: This AI tool lets doctors better understand your unique biology for sepsis detection
Prenosis co-founder and CEO Bobby Reddy Jr. discusses how artificial intelligence will change health care in treating sepsis on 'The Claman Countdown.'
Rotating shifts has a negative impact on sleep quality: Dr. Marty Makary
Fox News medical contributor Dr. Marty Makary weighs in on a new study that working irregular hours can harm your health during an appearance on ‘Varney & Co.’
Costco offers members access to Ozempic, Wegovy
Johns Hopkins professor of public health Dr. Marty Makary discusses Costco offering Ozempic and Wegovy to members and the use of these drugs.
Contrave mimics diet and exercise: George Hampton
Currax Pharmaceuticals President & CEO George Hampton breaks down the weight loss solution on 'The Claman Countdown.'
RBC analyst: Investors are more focused on the fundamentals of Tesla as opposed to anything going on personally with its CEO
RBC Capital global autos analyst Tom Narayan and Fox News medical contributor Dr. Marc Siegel discuss Elon Musk’s reported drug use on 'The Claman Countdown.'